Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
8.29
-0.06 (-0.72%)
Jul 3, 2025, 1:00 PM - Market closed
Teladoc Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -1,012 | -1,001 | -220.37 | -13,660 | -428.79 | -485.14 | Upgrade
|
Depreciation & Amortization | 228.46 | 249.81 | 265.76 | 221.69 | 219.62 | 70.59 | Upgrade
|
Other Amortization | 144.05 | 133.04 | 82.96 | 46.1 | - | 7.5 | Upgrade
|
Asset Writedown & Restructuring Costs | 849.14 | 790 | - | 13,403 | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | -5.9 | - | Upgrade
|
Stock-Based Compensation | 128.79 | 145.95 | 201.55 | 217.85 | 302.59 | 475.53 | Upgrade
|
Provision & Write-off of Bad Debts | 3.77 | 3.8 | 4.69 | 2.82 | 10.6 | 5.28 | Upgrade
|
Other Operating Activities | -16.26 | 8.65 | 3.79 | 5.95 | 139.86 | -36.79 | Upgrade
|
Change in Accounts Receivable | -17.78 | -0.38 | -10.25 | -49.06 | -11.17 | -21.09 | Upgrade
|
Change in Inventory | -5.14 | -9.75 | 24.1 | 14.8 | -19.49 | -24.73 | Upgrade
|
Change in Accounts Payable | 12.86 | -10.37 | -4.18 | 1.88 | 1.19 | -88 | Upgrade
|
Change in Unearned Revenue | -31.09 | -18.25 | -4.9 | 15.24 | 20.55 | 17.75 | Upgrade
|
Change in Other Net Operating Assets | 16.25 | 2.42 | 6.89 | -31.25 | -35.06 | 25.58 | Upgrade
|
Operating Cash Flow | 300.68 | 293.68 | 350.02 | 189.29 | 193.99 | -53.51 | Upgrade
|
Operating Cash Flow Growth | -13.05% | -16.10% | 84.91% | -2.42% | - | - | Upgrade
|
Capital Expenditures | -12.37 | -10.79 | -11.46 | -16.48 | -8.53 | -4.02 | Upgrade
|
Cash Acquisitions | -64.61 | - | - | - | -78.66 | -567.43 | Upgrade
|
Sale (Purchase) of Intangibles | -107.76 | -113.26 | -144.88 | -156.28 | -55.4 | -22.02 | Upgrade
|
Investment in Securities | -27.08 | - | - | 2.51 | 60.9 | 2.5 | Upgrade
|
Other Investing Activities | - | - | 0 | 2.51 | 8.72 | - | Upgrade
|
Investing Cash Flow | -211.81 | -124.05 | -156.35 | -167.74 | -72.98 | -590.98 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | - | 1,098 | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | - | -246.79 | Upgrade
|
Net Debt Issued (Repaid) | - | - | - | - | - | 850.87 | Upgrade
|
Issuance of Common Stock | 7.44 | 8.31 | 11.13 | 12.39 | 42.59 | 59.04 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | - | -26.7 | Upgrade
|
Other Financing Activities | -0.11 | -0 | -0.28 | -5.89 | -1.64 | -24.07 | Upgrade
|
Financing Cash Flow | 7.33 | 8.31 | 10.85 | 6.5 | 40.95 | 859.14 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.8 | -3.29 | 0.97 | -3.34 | -1.8 | 4.32 | Upgrade
|
Net Cash Flow | 95.4 | 174.65 | 205.49 | 24.7 | 160.16 | 218.97 | Upgrade
|
Free Cash Flow | 288.31 | 282.89 | 338.56 | 172.81 | 185.46 | -57.54 | Upgrade
|
Free Cash Flow Growth | -14.07% | -16.44% | 95.91% | -6.82% | - | - | Upgrade
|
Free Cash Flow Margin | 11.29% | 11.01% | 13.01% | 7.18% | 9.12% | -5.26% | Upgrade
|
Free Cash Flow Per Share | 1.68 | 1.66 | 2.06 | 1.07 | 1.18 | -0.64 | Upgrade
|
Cash Interest Paid | 17.32 | 17.32 | 17.42 | 17.36 | 18.84 | 14.89 | Upgrade
|
Cash Income Tax Paid | 9.52 | 8.95 | 7.24 | 2.51 | 3.97 | 1.32 | Upgrade
|
Levered Free Cash Flow | 243.04 | 229.78 | 303.95 | 176.62 | 241.62 | 206.75 | Upgrade
|
Unlevered Free Cash Flow | 257.99 | 244.65 | 317.88 | 190.34 | 292.34 | 244.22 | Upgrade
|
Change in Net Working Capital | 6.53 | 29.6 | -55.52 | -13.38 | 16.57 | 22 | Upgrade
|
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.